Cite
HARVARD Citation
Karas, S. et al. (2022). Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Advanced Cancer Patients: Influence of Demographic and Clinical Factors. Clinical pharmacology & therapeutics. 112 (2), pp. 316-326. [Online].